Feedback / Questions
prexigebersen (BP1001) - Bio-path
Sprycel (dasatinib) - BMS, Otsuka, Inhibikase
https://www.globenewswire.com/news-release/2020/01/08/1967804/0/en/Bio-Path-Holdings-Provides-Clinical-Update-and-2020-Business-Outlook.html
Jan 8, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next